Arcoxia 90

What is Arcoxia? Arcoxia (Etoricoxib) is a selective inhibitor of cyclooxygenase-2 (COX-2), an enzyme involved in pain and inflammation. It is a member of the COX-2-selective (coxib) class of nonsteroidal antiinflammatory drugs (NSAIDs). Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. Discover how Arcoxia works, what it's used for, real user experiences, side effects, and expert tips for safe use. Everything you want to know before starting. Arcoxia is a medicine used in the treatment of osteoarthritis. Find out more about how it works, who can take it, and the possible side effects. Arcoxia (etoricoxib) is used to treat osteoarthritis and rheumatoid arthritis. Includes Arcoxia side effects, interactions and indications. Arcoxia is used to treat various types of pain and inflammation. The medication is commonly used to treat conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, and acute pain. Further reading and references Manufacturer's PIL, Arcoxia® 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets; Organon Pharma (UK) Ltd, The electronic Medicines Compendium. Dated April 2022. Medicines Complete BNF 89th Edition; British Medical Association and Royal Pharmaceutical Society of Great Britain, London.

Meta: